FDA
-
-
-
-
-
-
-
Sucampo (SCMP) Reports FDA Acceptance of sNDA for AMITIZA in Children with Pediatric Functional Constipation, with Priority Review Designation
-
-
-
-
-
-
-
Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
-
-
322,231 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

